Literature DB >> 31262453

The mechanisms of traditional Chinese medicine underlying the prevention and treatment of atherosclerosis.

Ting-Ting Li1, Zhi-Bin Wang1, Yang Li1, Feng Cao1, Bing-You Yang1, Hai-Xue Kuang2.   

Abstract

Atherosclerosis (AS) is a chronic inflammatory disease associated with high morbidity and mortality. The incidence of AS is increasing in the last decades. So development of safe and effective therapeutics for treating AS has become prominently important. Although there are numerous chemical drugs available for treating AS, some drugs are not effective and some have serious side effects. Traditional Chinese medicine (TCM) has a long history for the prevention and treatment of AS due to its less side effects and superior efficacy. This paper describes the effectiveness and underlying mechanisms for prevention and treatment of AS by TCM or its active components. Some TCM, e.g. XuemaiNing, Tongxinluo and Salvia miltiorrhiza have been reported to have cardio-protective effect. Some active components of TCM, e.g. saikosaponin-A, kuwanon G, luteolin and β-elemene have been isolated from various TCM and demonstrated to have beneficial effects on prevention and treatment of AS.
Copyright © 2019 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Mechanism; Traditional Chinese medicine

Mesh:

Substances:

Year:  2019        PMID: 31262453     DOI: 10.1016/S1875-5364(19)30048-2

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  14 in total

Review 1.  Advances in Glycolysis Metabolism of Atherosclerosis.

Authors:  Ruhan Xu; Wei Yuan; Zhongqun Wang
Journal:  J Cardiovasc Transl Res       Date:  2022-09-06       Impact factor: 3.216

Review 2.  NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis.

Authors:  Yang Liu; Chao Li; Honglin Yin; Xinrong Zhang; Yunlun Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-31       Impact factor: 2.629

3.  Tetramethylpyrazine Induces Apoptosis and Inhibits Proliferation of Hypertrophic Scar-Derived Fibroblasts via Inhibiting the Phosphorylation of AKT.

Authors:  Xue Wu; Zheng Wang; Gaofeng Wu; Xiaofan Xu; Jian Zhang; Yan Li; Hong Zhang; Shuzhen Guo
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810

4.  Salvia miltiorrhiza and the Volatile of Dalbergia odorifera Attenuate Chronic Myocardial Ischemia Injury in a Pig Model: A Metabonomic Approach for the Mechanism Study.

Authors:  Rui Lin; Fei Mu; Yao Li; Jialin Duan; Meina Zhao; Yue Guan; Kedi Liu; Yang Bai; Aidong Wen; Peifeng Wei; Jingwen Wang; Miaomiao Xi
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

5.  Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway.

Authors:  Zhuo Feng; Changyuan Wang; Qiang Meng; Jingjing Wu; Huijun Sun
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 6.  Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review.

Authors:  Shiqi Chen; Xiaoxiao Wu; Tong Li; Yang Li; Baofu Wang; Weiting Cheng; Yu Teng; Jingjing Yang; Hui Meng; Lei Wang; Ziwen Lu; Yangyang Jiang; Yahong Wang; Mingjing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-27       Impact factor: 2.629

Review 7.  Targeting Reactive Oxygen Species in Atherosclerosis via Chinese Herbal Medicines.

Authors:  Leyi Zhang; Jiaqin Huang; Danli Zhang; Xiaojing Lei; Yan Ma; Yun Cao; Jingling Chang
Journal:  Oxid Med Cell Longev       Date:  2022-01-10       Impact factor: 6.543

8.  Knockdown of mesenchymal stem cell‑derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARγ/LXRα/ABCA1 signaling pathway.

Authors:  Limin Sun; Xin He; Tao Zhang; Yaling Han; Guizhou Tao
Journal:  Int J Mol Med       Date:  2021-10-05       Impact factor: 4.101

9.  Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis.

Authors:  Kailin Yang; Liuting Zeng; Anqi Ge; Xiaoping Pan; Tingting Bao; Zhiyong Long; Qiaozhen Tong; Mengxia Yuan; Xiaofei Zhu; Jinwen Ge; Zhengde Huang
Journal:  J Cell Mol Med       Date:  2020-11-02       Impact factor: 5.295

10.  Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPAR-γ signaling based on network pharmacology and experimental validation.

Authors:  Baohua Zhang; Zhongwei Hao; Wenli Zhou; Shan Zhang; Mingyan Sun; Honglei Li; Naijing Hou; Cui Jing; Mingxing Zhao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.